Got a Question?
If you have a question for our guest, host or DRG please submit it here.
Wuhan experience shapes the new normal for healthcare
Guest: Christian Hogg, CEO of Hutchison China MediTech
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Christian Hogg, CEO of Hutchison China MediTech about how the organisation has tackled the impacts of COVID-19 on business globally. Christian gives us a month-by-month account from January to May of how they mitigated disruption and moved to a place of “new normal”, most notably within business activities related to commercial operations and getting vital medication to patients on clinical trials. With China slightly ahead of the pandemic curve from a timing perspective, what takeaways can the rest of the world utilise to ensure quicker recovery to the business of healthcare?
About our Guest
Christian Hogg, CEO of Hutchison China MediTech
Christian joined Chi-Med in 2000, as its first employee, and has since led all aspects of the creation, implementation and management of the company’s strategy, business and listings. This includes the establishment of its Innovation Platform, Hutchison MediPharma, which now comprises eight drug candidates that are being investigated in clinical studies around the world and a scientific team of over 490 people. Furthermore, Christian oversaw the acquisition and operational integration of assets that led to the formation of Chi-Med’s Commercial Platform, which manufactures, markets and distributes prescription drugs and consumer health products, covering an extensive network of hospitals across China.
About our Host
Mike Ward, Head of Thought Leadership, DRG
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership roles at various publications and organizations across the industry.
